These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11286732)

  • 21. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
    Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
    J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis.
    Lahey T; von Reyn CF
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG - old workhorse, new skills.
    Gengenbacher M; Nieuwenhuizen NE; Kaufmann S
    Curr Opin Immunol; 2017 Aug; 47():8-16. PubMed ID: 28719821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis.
    Roche PW; Triccas JA; Avery DT; Fifis T; Billman-Jacobe H; Britton WJ
    J Infect Dis; 1994 Nov; 170(5):1326-30. PubMed ID: 7963739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
    Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
    Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond BCG: the potential for a more effective TB vaccine.
    Orme IM
    Mol Med Today; 1999 Nov; 5(11):487-92. PubMed ID: 10529790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current status, challenges, and future developments of new tuberculosis vaccines.
    Gong W; Liang Y; Wu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1697-1716. PubMed ID: 29601253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination of mice with recombinant bacille Calmette-Guérin harboring Rv1357c protects similarly to native BCG.
    Flores-Valdez MA; Aceves-Sánchez MJ; Montero-Pérez SA; Sánchez-López AD; Gutiérrez-Pabello JA; Hernández-Pando R
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):774-6. PubMed ID: 22507759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.